Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 685 (LINC00685) is a member of the long non-coding RNA family, specifically classified as a long intergenic non-coding RNA (lincRNA), which means it is transcribed from a genomic region not overlapping with protein-coding genes[1][6][3]. Its primary molecular function, like many lincRNAs, is likely regulatory, with roles in modulating chromatin architecture, influencing transcriptional processes, and potentially acting as a decoy or sponge for microRNAs[5][7]. LINC00685 has been reported to be highly expressed in hepatocellular carcinoma and its expression is associated with more advanced tumor grade, TNM staging, and patient recurrence, suggesting it may have a role in the progression of some cancers[2]. There are currently no reported drugs or therapeutic agents directly targeting this lincRNA, nor is it considered a classical therapeutic target such as a receptor, enzyme, or transporter. Its functional mechanism may involve acting as a regulatory RNA for cellular gene expression, and further research is required to fully elucidate its disease associations and clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 685 (LINC00685).